Welcome
Support Centre
06 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Prospective, double-blind, randomised trial to assess the efficacy of continuous sciatic/posterior tibial nerve blockade via a neural sheath catheter in lower limb amputees
ISRCTN ISRCTN68691928
ClinicalTrials.gov identifier
Public title Prospective, double-blind, randomised trial to assess the efficacy of continuous sciatic/posterior tibial nerve blockade via a neural sheath catheter in lower limb amputees
Scientific title
Acronym N/A
Serial number at source 56481676
Study hypothesis That continuous neural sheath infusion of levobupivacaine after major lower limb amputation will reduce the incidence of late phantom pain/phantom limb sensations and stump pain.
Ethics approval Ethics approval received from the Trent Research Ethics Committee on the 13th August 2007 (ref: 07/H0405/42).
Study design Randomised placebo controlled double blind study
Countries of recruitment United Kingdom
Disease/condition/study domain Lower limb amputation
Participants - inclusion criteria Patients admitted to our vascular unit requiring a below or above knee amputation irrespective of aetiology.
Participants - exclusion criteria 1. Patients not considered for surgical intervention
2. Patients who are deemed unfit to undergo surgery under general anaesthesia
3. Patients unable to operate a Patient-Controlled Analgesia (PCA) device or cooperate with evaluation of pain scores e.g. those with confusional states
4. Patients unwilling to consent
5. Allergy to any study medication
Anticipated start date 01/07/2007
Anticipated end date 01/01/2010
Status of trial Ongoing
Patient information material
Target number of participants 62
Interventions Perineural infusion of levobupivacaine 1.25 mg/ml versus placebo for 96 hours after surgery.
Primary outcome measure(s) Late stump pain, phantom limb sensations and phantom limb pain up to one year after surgery.
Secondary outcome measure(s) 1. Early postoperative pain and morphine requirements
2. Late effects on mood, physical disability and quality of life, measured using the Late Life disability index (quality of life and disability), the 36-item Short Form health survey (SF-36) inventory, (pain and disability) the McGill pain questionnaire (pain) and the University of Leicester Amputee questionnaire (pain and disability)

Secondary outcomes will be measured at 6 weeks, 3, 6 and 12 months after surgery.
Sources of funding Association of Anaesthetists of Great Britain and Ireland (UK)
Trial website
Publications
Contact name Dr  Jonathan  Thompson
  Address University Hospitals of Leicester NHS Trust
Department of Anaesthesia Critical Care and Pain Management
Victoria Building
Leicester Royal Infirmary
  City/town Leicester
  Zip/Postcode LE1 5WW
  Country United Kingdom
  Tel +44 (0)116 258 5291
  Email jt23@le.ac.uk
Sponsor University Hospitals of Leicester NHS Trust (UK)
  Address c/o Professor David Rowbotham
Research Office
Leicester General Hospital
Gwendolen Road
  City/town Leicester
  Zip/Postcode LE5 4PW
  Country United Kingdom
  Tel +44 (0)116 258 4199
  Fax +44 (0)116 258 4226
  Email djr8@le.ac.uk
  Sponsor website: http://www.uhl-tr.nhs.uk/
Date applied 29/05/2007
Last edited 21/09/2007
Date ISRCTN assigned 16/07/2007
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central